The Venture Codex Logo

The Venture Codex

Overview

Biopharmaceutical company developing mirror image nucleic acid therapies.

Total Raised

$47 M

Rounds

4

Links

Verticals

Biotechnology
Health Care
Pharmaceutical

Investment History

  1. Debt Financing

    Aug 2025

    $1M

  2. Equity

    Dec 2023

    $3M

  3. Series D

    Oct 2010

    $3M

  4. Series D

    May 2010

    $41M

Team

Diede van den Ouden

CEO and board of directors

Frank Morich

CEO

Walter Wenninger

Chairman of the Board

Jarl Ulf Jungnelius

CMO